09/10/2026
Running a small or startup biotech in the UK? You could be leaving R&D tax relief on the table! 🧬
Many founders miss costs that qualify, like reagents (even from experiments that didn’t work out) and the time scientists spend writing papers or presenting at conferences.
And if you’re pre-revenue, the Enhanced R&D Intensive Support scheme could return up to 27% of your qualifying R&D spend as cash, with no equity given away.
Our new guide covers what counts, worked examples, how to claim, and a deadline that catches first-time claimants out.
👉 https://www.leraccountancy.co.uk/knowledge/rd-tax-credits-for-biotech-companies-uk/
Got questions? Send us a message, we’re happy to help!
Biotech companies recover up to 27% of qualifying R&D costs. 2026 guide to lab consumables, staff, clinical trials and how to claim.